Barclays PLC Eton Pharmaceuticals, Inc. Transaction History

Barclays PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.66 - $6.59 $7,821 - $14,082	-2,137 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$4.2 - $6.26 $7,782 - $11,599	-1,853 Reduced 46.44%	2,137 $11,000
Q2 2021 Aug 13, 2021	SELL	$5.71 - $8.85 $58,744 - $91,048	-10,288 Reduced 72.05%	3,990 $25,000
Q1 2021 May 13, 2021	BUY	$6.93 - $10.07 $60,755 - $88,283	8,767 Added 159.08%	14,278 $104,000
Q4 2020 Feb 11, 2021	SELL	$6.65 - $8.83 $8,039 - $10,675	-1,209 Reduced 17.99%	5,511 $45,000
Q3 2020 Nov 12, 2020	SELL	$4.96 - $9.06 $6,666 - $12,176	-1,344 Reduced 16.67%	6,720 $53,000
Q2 2020 Aug 12, 2020	BUY	$3.5 - $6.09 $28,224 - $49,109	8,064 New	8,064 $45,000
Q2 2019 Aug 14, 2019	SELL	$7.1 - $8.39 $62,480 - $73,832	-8,800 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$5.72 - $8.0 $50,336 - $70,400	8,800 New	8,800 $70,000

9.44M

261K

500

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $318M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.